dc.contributor.author |
Colebunders, R. |
en_US |
dc.contributor.author |
Apers, L. |
en_US |
dc.contributor.author |
Dieltiens, G. |
en_US |
dc.contributor.author |
Worodria, W. |
en_US |
dc.date.accessioned |
2007-12-06T14:38:16Z |
|
dc.date.available |
2007-12-06T14:38:16Z |
|
dc.date.issued |
2007 |
en_US |
dc.identifier.issn |
0959-8146 |
en_US |
dc.identifier.doi |
http://dx.doi.org/10.1136/bmj.39092.388796.80 |
|
dc.identifier.other |
ITG-C1A |
en_US |
dc.identifier.other |
ITG-C2A |
en_US |
dc.identifier.other |
ITG-H3A |
en_US |
dc.identifier.other |
CLINIC |
en_US |
dc.identifier.other |
U-HIVCLI |
en_US |
dc.identifier.other |
HEALTH |
en_US |
dc.identifier.other |
U-EPID |
en_US |
dc.identifier.other |
JIF |
en_US |
dc.identifier.other |
DOI |
en_US |
dc.identifier.other |
FTA |
en_US |
dc.identifier.other |
MULTI |
en_US |
dc.identifier.uri |
http://hdl.handle.net/10390/818 |
|
dc.language |
English |
en_US |
dc.publisher |
BMJ Publishing Group |
en_US |
dc.subject |
Bacterial diseases |
en_US |
dc.subject |
Tuberculosis |
en_US |
dc.subject |
Co-infections |
en_US |
dc.subject |
Viral diseases |
en_US |
dc.subject |
HIV |
en_US |
dc.subject |
AIDS |
en_US |
dc.subject |
Interventions |
en_US |
dc.subject |
Effectiveness |
en_US |
dc.subject |
Integrated control |
en_US |
dc.subject |
Antiretrovirals |
en_US |
dc.subject |
Drug availability |
en_US |
dc.subject |
Chemoprophylaxis |
en_US |
dc.subject |
Antimicrobial agents |
en_US |
dc.subject |
Isoniazid |
en_US |
dc.subject |
Accessibility |
en_US |
dc.subject |
Health care seeking behavior |
en_US |
dc.subject |
Voluntary counseling and testing (VCT) |
en_US |
dc.subject |
Compliance |
en_US |
dc.subject |
Drug resistance |
en_US |
dc.subject |
Developing countries |
en_US |
dc.title |
Tuberculosis in resource poor countries; better access to antiretroviral therapy and isoniazid prophylaxis offer new opportunities for control [editorial] |
en_US |
dc.type |
Editorial |
en_US |
dc.type |
Article |
en_US |
dc.citation.issue |
7585 |
en_US |
dc.citation.jtitle |
BMJ |
en_US |
dc.citation.volume |
334 |
en_US |
dc.citation.pages |
105-106 |
en_US |
dc.publisher.place |
London |
en_US |
dc.identifier.pmid |
http://www.ncbi.nlm.nih.gov/pubmed/16359399 |
|
dc.citation.jabbreviation |
BMJ |
en_US |